| Code | 1260F | ||||||||||
| MA number | EU/1/25/1961/002 | ||||||||||
| Product Form: | sol inj 1x11,12 mg/0,278 ml (liek.inj.skl+filtr.ihla) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Zakłady Farmaceutyczne Polpharma S.A., Poland | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Intravitreal use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(4) similar biological application |
| MA issued: | 14.08.2025 |
| Validity: | 14.08.2030 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Aflibercept_Príručka pre pacienta.pdf
|
| Dokument: |
Aflibercept_Príručka pre predpisujúceho lekára.pdf
|
| Safety feature | Yes |
| Data update: | 25.09.2025 |
